Drug Type Small molecule drug |
Synonyms PSMA Targeting T Cell Engager(GSK), GSK5458514 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic castration-resistant prostate cancer | Phase 2 | United States | 12 Jun 2025 | |
Metastatic castration-resistant prostate cancer | Phase 2 | Japan | 12 Jun 2025 | |
Metastatic castration-resistant prostate cancer | Phase 2 | Canada | 12 Jun 2025 | |
Metastatic castration-resistant prostate cancer | Phase 2 | United Kingdom | 12 Jun 2025 |